Search

everythinglearnresearchcommunity

for

Search:↓

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Higher minoxidil dose helps hair growth in non-responders without side effects.

Increasing the dosage of minoxidil can help hair regrowth in women who didn't respond to the standard treatment.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

60% of women who didn't respond to 5% minoxidil for hair loss showed significant improvement with a 15% minoxidil solution.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Cells that move well may improve hair loss treatments by entering hair follicles.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

Higher IGF-1 levels in hair follicles link to better finasteride results for hair loss.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Tofacitinib may help treat severe hair loss, but more research is needed.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.